Breath Analysis by Ion Mobility Spectrometry

This study is currently recruiting participants.

Verified May 2011 by Lung Clinic Hemer

Sponsor:

Information provided by:

Lung Clinic Hemer

ClinicalTrials.gov Identifier:

NCT00632307

First received: February 29, 2008

Last updated: June 22, 2011

Last verified: May 2011

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	June 2015
Estimated Primary Completion Date:	May 2014 (Final data collection date for primary outcome measure)

Publications:

Bunkowski A, Bödeker B, Bader S, Westhoff M, Litterst P, Baumbach JI. MCC/IMS signals in human breath related to sarcoidosis-results of a feasibility study using an automated peak finding procedure. J Breath Res. 2009 Dec;3(4):046001. Epub 2009 Sep 23.

Westhoff M, Litterst P, Freitag L, Urfer W, Bader S, Baumbach JI. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Thorax. 2009 Sep;64(9):744-8. Epub 2009 Jan 21.

Westhoff M, Litterst P, Freitag L, Baumbach JI. Ion mobility spectrometry in the diagnosis of sarcoidosis: results of a feasibility study. J Physiol Pharmacol. 2007 Nov;58 Suppl 5(Pt 2):739-51.

Bunkowski,A, Bödeker B, Bader S, Westhoff M, Litterst P, Baumbauch JI.Signals in human breath related to Sarcoidosis. — Results of a feasibility study using MCC/IMS. Int. J. Ion Mobil. Spec. (2009) 12:73-79

To Top